You have commented 358 times on Rantburg.

Your Name
Your e-mail (optional)
Website (optional)
My Original Nic        Pic-a-Nic        Sorry. Comments have been closed on this article.
Bold Italic Underline Strike Bullet Blockquote Small Big Link Squish Foto Photo
Submit your comments on this article
Government Corruption
FDA Finally Approved An Alzheimer's Drug... But Everything Surrounding It Is Controversial
2022-08-23
[ZERO] Aduhelm is the brand name under which the Alzheimer’s drug Aducanumab is marketed. It is developed by the U.S. company Biogen. The drug is to be administered as an intra-venous infusion every four weeks.

The Food and Drug Administration (FDA) approved Aducanumab in June 2021, making it the first Alzheimer’s disease medication approved by the FDA since 2003. It is also the first ever approved Alzheimer’s drug targeting the presence of amyloid beta (a type of protein) plaques in the brain.

However, almost everything about this drug is controversial, from the theory on which the drug is developed, to its clinical trials data, to the FDA approval itself. This article aims to distill the complicated information down to a few points, which might help patients make more informed decisions.
Posted by:Besoeker

#7  Years of Alzheimer's research were based on a key finding. Now an investigation alleges it was faked, and the work may have been wasted.
Posted by: Snash Shairt9621   2022-08-23 14:04  

#6  They've been chasing amyloid beta and tau for 20 years. Drugs have been trialed that reduce these proteins, they just don't do anything about Alzheimer's. They are hitting their target. It's just the wrong one.
Posted by: Angstrom   2022-08-23 09:42  

#5  'Blue Brain'
Posted by: Skidmark   2022-08-23 09:23  

#4  Painful brain swelling is a hangover symptom.
Posted by: M. Murcek    2022-08-23 08:23  

#3  ^^ From National Council On Aging (NCOA)
Posted by: Mullah Richard   2022-08-23 07:45  

#2  

What are Aduhelm's side effects?

The most common side effect is painful brain swelling, which occurred in about 35% of patients in the clinical trials. Biogen reports that this side effect is most commonly seen as short-term swelling in areas of the brain that usually resolves over time. Some people may also have small spots of bleeding in or on the surface of the brain with the swelling. Over 20% of people in clinical trials had headaches related to the brain swelling. Healthcare providers prescribing Aduhelm will be required to do magnetic resonance imaging (MRI) scans before and during treatment with AduhelmTM to check for brain swelling.

In addition, 8-9% of clinical trial participants experienced confusion, delirium, disorientation, vision changes, and diarrhea. Falls occurred in 15% of the patients taking Aduhelm during the clinical trials. Allergic reactions, such as swelling of the face, lips, mouth, or tongue and hives, can occur during an Aduhelm infusion.
Posted by: Mullah Richard   2022-08-23 07:44  

#1  Caution: Do not attempt to ride a bicycle within 48 hours of taking Aduhelm.
Posted by: Besoeker   2022-08-23 01:40  

00:00